Trulieve Cannabis Corp. TRLV
At closeNov 10, 2026, 4:22 AM EST
Pre-market · Nov 10, 4:22 AM ET
- YTD
- +26.70%
- 1 year
- +68.09%
- Market cap
- 1.88B
- Revenue (ttm)
- 1.08B
- Profit margin
- -41.22%
- EPS (ttm)
- -2.31
- Shares out
- 170.41M
- Forward P/E
- 21.19
- YTD return
- +26.70%
- 1-year return
- +68.09%
- Volume
- 1.90M
- Avg volume
- 1.77M
- Open
- 11.57
- Previous close
- 11.56
- Day's range
- 10.71 – 11.65
- 52-week range
- 4.62 – 13.28
- Analysts
- Strong Buy
- Price target
- 18.32 (+66.4%)
- Earnings date
- Feb 4, 2027
5D -0.50 (-4.34%)
Key statistics
- Enterprise value
- 2.23B
- PEG ratio
- 0.00
- Price / sales
- 1.74
- Price / book
- 2.75
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -20.10%
- Free cash flow
- 150.19M
- Total cash
- 326.69M
- Total debt
- 582.20M
- Return on equity
- -45.58%
- Short % of float
- 4.36%
- 50-day average
- 11.21
- 200-day average
- 8.89
Analyst view
Consensus: strong buy
- Target (low)
- 15.00
- Target (mean)
- 18.32
- Target (high)
- 22.00
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 0.12.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 0.10 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 0.0925 | 0.09 | 0.00 | -2.70% |
| Aug 6, 2026 | Jun 30, 2026 | 0.06 | -2.11 | -2.17 | -3,616.67% |
| May 7, 2026 | Mar 31, 2026 | -0.01412 | 0.01 | +0.02 | +170.82% |
| Feb 26, 2026 | Dec 31, 2025 | -0.07427 | -0.22 | -0.15 | -196.22% |
| Nov 5, 2025 | Sep 30, 2025 | -0.08458 | -0.14 | -0.06 | -65.52% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Oct 23, 2026 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 7, 2026 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Jul 20, 2026 | Cantor Fitzgerald | init | — | Overweight |
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- trulieve.com
News
Trulieve Cannabis Q3 Adj. EPS $0.09 Beats $0.05 Estimate, Sales $230.000M Beat $218.321M Estimate 
Trulieve Reports Third Quarter 2026 Results 
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target - Trulieve Cannabis Awarded Registrations For Medical Marijuana Dispensaries From U.S. Drug Enforcement Administration
Deckers Outdoor Posts Mixed Q2 Results, Joins BayCom, Five Point Holdings And Other Big Stocks Moving Lower In Friday’s Pre-Market Session 
Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target 
Full Transcript: Trulieve Cannabis Q2 2026 Earnings Call
Your note
Sign in to keep a note on TRLV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BESHEARS THAD | Director | Stock Award(Grant) | Mar 12, 2026 | 2,487,040 |
| COLLINS GINA | Officer | Stock Award(Grant) | Aug 11, 2025 | 188,916 |
| HERSEY CHRISTINE ANN | Officer | Stock Award(Grant) | Mar 12, 2026 | 143,767 |
| JHALA NILYUM | Chief Technology Officer | Stock Award(Grant) | Mar 12, 2026 | 246,254 |
| LANDRUM KYLE FINN | Officer | Stock Award(Grant) | Mar 12, 2026 | 258,776 |
| MAY RICHARD SUBER | Director | Stock Award(Grant) | Mar 12, 2026 | 593,534 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Investments, LLC | 6.24% | 10,641,152 | 117.27M | Jun 29, 2026 |
| Nomura Holdings Inc. | 2.97% | 5,065,849 | 55.83M | Jun 29, 2026 |
| Cantor Fitzgerald, L.P. | 2.20% | 3,750,000 | 41.33M | Jun 29, 2026 |
| Marex Group Ltd. | 1.91% | 3,250,000 | 35.82M | Jun 29, 2026 |
| ING Groep N.V. | 1.56% | 2,665,000 | 29.37M | Jun 29, 2026 |
| Oakmont Corp | 0.88% | 1,506,511 | 16.60M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF | 14.89% | 25,375,468 | 279.64M | Oct 30, 2026 |
| AdvisorShares Trust-AdvisorShares Pure Cannabis ETF | 0.28% | 471,907 | 5.20M | Oct 30, 2026 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 0.13% | 223,916 | 2.47M | Sep 29, 2026 |
| Northern Funds-SMALL CAP VALUE FUND | 0.03% | 55,312 | 609.54K | Jun 29, 2026 |
| TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fund | 0.02% | 39,800 | 438.60K | Jun 29, 2026 |